Latest stories on SLXN
Silexion Therapeutics Corp (SLXNW) files 8-K
SEC 8-K50 · neutralgeneral
Silexion Therapeutics Begins Global SIL204 Pancreatic Cancer Trial
TipRanks63 · neutralproduct/pr
Silexion announces first patient dosed in Phase 2/3 trial of SIL204
The Fly63 · neutralproduct/pr
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Business Insider67 · bullishproduct/pr
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
GlobeNewswire67 · bullishproduct/pr
Silexion Therapeutics Announces Warrant Inducement Financing Deal
TipRanks34 · bearishgeneral
SLXN Jumps After SIL204 Preclinical Data Shows KRAS Knockdown Using Normal Serum Lipids
September 29, 2026
MarketChameleon67 · bullishproduct/pr
Silexion Therapeutics Corp (SLXNW) files 8-K
SEC 8-K50 · neutralgeneral
Silexion Therapeutics Announces Exercise of Warrants
GlobeNewswire50 · neutralgeneral
Silexion Therapeutics Announces Exercise of Warrants
StockTitan50 · neutralgeneral
Silexion Highlights Positive Translational Data for RNAi Oncology
TipRanks67 · bullishproduct/pr
Silexion Therapeutics reports preclinical findings for SIL204
The Fly59 · neutralproduct/pr
Silexion Therapeutics Corp (SLXNW) files 8-K
SEC 8-K34 · bearishgeneral
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
Business Insider56 · neutralgeneral
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
GlobeNewswire56 · neutralgeneral
Silexion Therapeutics Corp (SLXNW) files 8-K
SEC 8-K34 · bearishgeneral
Silexion Therapeutics GAAP EPS of -$5.17
Seeking Alpha28 · bearishearnings
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire59 · neutralproduct/pr
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider63 · neutralproduct/pr
Silexion Therapeutics Closes Public Offering and Strengthens Equity
TipRanks24 · bearishgeneral
Silexion Therapeutics Corp (SLXNW) files 8-K
SEC 8-K50 · neutralgeneral
Silexion Therapeutics prices $2.5M public offering
Seeking Alpha24 · bearishgeneral
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
StockTitan24 · bearishgeneral